An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury in severe COVID-19 cases, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.
The eighth episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features Rich Horgan ‘14, founder of Cure Rare Disease, a non-profit biotech company.
Many in the workforce have turned to Nellie Brown, director of Workplace Health and Safety Programs at the ILR School, for guidance on how to keep their workplaces safe from COVID-19
Scientists at Weill Cornell Medicine have developed a pipeline that will enable study of the biological roles of gut bacteria, recognized as key factors in health and disease.
A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease, according to a new discovery from Weill Cornell Medicine researchers.
According to new research out of Weill Cornell Medicine, a protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body.
Using an innovative new imaging technique, researchers at Weill Cornell Medicine have revealed the inner workings of a family of light-sensing molecules in unprecedented detail and speed.
Cornell's Office of Academic Integration has announced 15 new multi-investigator seed grants, including support for a project on climate change, pollen and asthma attacks and another to develop a microbial delivery system for a unique treatment of colorectal cancer.
Cornell researchers have for the first time imaged the entire depth of the lymph nodes in a living mouse using three-photon microscopy, which enabled them to observe the dynamic interactions of immune cells.
